Feedback / Questions
Ebglyss (lebrikizumab-lbkz) - Eli Lilly
Adbry (tralokinumab-ldrm) - LEO Pharma, AstraZeneca
Nemluvio (nemolizumab-ilto) - Galderma
Dupixent (dupilumab) - Sanofi, Regeneron
http://www.ncbi.nlm.nih.gov/pubmed/42643725
Hiroyuki Tanaka; Toshihiro Ishii
Aug 27, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next